Læknablaðið - 01.10.1979, Page 56

258
LÆKNABLAÐIÐ
38. Hambling M.H.: Effect of a vaccination
programme on the distribution of rubella
antibodies in women of childbetu’ing age.
Lancet, May 17, 1130—1133, 1975.
39. Herrmann K.L., Halstead S.B., Brandling-
Bennett A.D., Witte J.J., Wiebenga N.H.,
Eddins D.L.: Rubella immunization, Persi-
stence of antibody four years after a large-
scale field trial. Jama 235: 2201—2204,
1976.
40. Hillary I.B.: Persistence of antibody after
subcutaneous vaccination with Wistar RA
27/3 rubella vaccine. J. Hyg. Camb. 69:
369—372, 1971.
41. Hillary I.B., Freestone D.S.: Persistence of
antibody induced by rubella vaccine (Wis-
tar 27/3 strain) after six years. J. Hyg.
Camb. 75: 407—411, 1975.
42. Holt S., Hudgins D., Krishman K.R., Critch-
ley E.M.R., Diffuse myelitis associated with
rubella vaccination. Brit. Med. Journ. 2:
1037—1038, 1976.
43. Horstmann D.M., Liebhaber H., Le Bouvier
G.L., Rosenberg M.D.A., Halstead S.B.: Ru-
bella: reinfection of vaccinated and natu-
ral immune persons, exposed in an epide-
mic. New Engl. J. Med. 283: 771—778, 1970.
44. Horstmann D.M.: Controlling rubella:
problems and perspectives. Ann. Int. Med.,
83: 412—417, 1975.
45. Katz M.: Rubella vaccine. Journ. Ped. 84:
615—616, 1974.
46. Kilroy A.W., Schaffner W., Fleet W.F.,
Lefkowitz L.B., Karzon D.T., Fenichel G.
M.: Two syndrome following rubella im-
munization. Jama 214: 2287—2292, 1970.
47. Klock L.E., Spruance S.L., Bailey A., Mc-
Quarrie H.G., Herbertson R.M., Sharp H.C.,
Smith C.B.: A clinical and serological study
of women exposed to rubella vaccines.
Am. J. Dis. Child. 123: 465—468, 1972.
48. Klock L.E., Rachelefsky G.S.: Failure of
rubella herd immunity during an epide-
mic. New Engl. J. Med. 288: 69—72, 1973.
49. Krugman S.: Present status of measles
and rubella immunization in the United
States: A medical progress report.
Journ. Ped. 90: 1—12, 1977.
50. Landrigan P.J., Stoffels M.A., Anderson E.,
Witte J.J.: Epidemic rubella in adolecent
boys. Jama 227: 1283—1287, 1974.
51. Larson H.E., Parkman P.D., Davis W.J.,
Hopps H.E., Meyer M.H.: Inadvertent ru-
bella virus vaccination during pregnancy.
New Engl. J. Med. 284: 870—873, 1971.
52. Lefkowitz L.B., Rafajko R.R., Federspiel
C.F., Quinn R.W.: A controlled famil study
of live, attenuated rubeila-virus vaccine.
New Engl. J. Med. 283: 229—232, 1970.
53. Lehane D.E., Newberg N.R., Beam W.E.:
Evaluation of rubella herd immunity dur-
ing an epidemic. Jama 213: 2236.—2239,
1970.
54. Liebhaber H., Ingalls T.H., Le Bouvier
G.L., Horstmann D.M.: Vaccination with
RA 27/3 rubella vaccine. Am. J. Dis. Child.
123: 133—136, 1972.
55. Lipman R.P., Bethel M.B., Wooten J.H.,
Levine R.H., Pagano J.S.: Attenuated ru-
bella vaccine (HPV-77): evaluation in a
large controlled trial. Am. J. Public Health
61: 1392—1402, 1971.
56. Meyer H.M., Parkman P.D., Hobbins T.E.,
Larson H.E., Davis W.J., Simsarian J.P.,
Hopps H.E.: Attenuated rubella viruses.
Am. J. Dis. Child. 118: 155—165, 1969.
57. Meyer H.M., Parkman P.D.: Rubella vac-
cination. A review of practical experience.
Jama. 215: 613—619, 1971.
58. Modlin J.F., Brandling-Bennett A.D., Witte
J.J., Campbell C.C., Meyers J.D.: A review
of five years experience with rubella vac-
cine in the United States. Pediatric. 55:
20—28, 1975.
59. Modlin J.F., Herrmann K., Brandling-
Bennett A.D., Eddins DL., Hayden G.F.:
Risk of congenital abnormality after in-
advertent rubella vaccination of pregnant
women. New Engl. J. Med. 294 : 972—974,
1976.
60. Monif G.R.G., Held B.: Non contagiousness
of the Cendehill vaccine strain of rubella
virus from mother to newborn infant.
Journ. Ped. 78 (2): 306—307, 1971.
61. Naficy K., Nategh R., Ahangary S., Moh-
senia H.: Artificial challenge studies in
rubella. Am. J. Dis. Child. 120: 520—523,
1970.
62. Northorp R.L., Gardner W.M., Geittmann
W.: Rubella reinfection during early preg-
nancy. Obst. Gyn. 39: 524—526, 1972.
63. Ogra P.L., Herd J.K.: Arthritis associated
with induced rubella infection. J. Immu-
nol. 107: 810—813, 1971.
64. Ogra P.L., Kerr-Grant D., Umana G.,
Dzierba J., Weintraub D.: Antibody res-
ponse in serum and nasopharynx after na-
turally acquired and vaccine induced in-
fection with rubella virus. New Engl. J.
Med. 285: 1333—1339, 1971.
65. Plotkin S.A., Farquhar J.D.: Immunity to
rubella: comparison between naturally and
artificially induced resistence. Postgrad
Med. J. July supply 3 : 47—54, 1972.
66. Prinzie A., Huygelen C., Gold J., Farqu-
har J., McKee J.: Experimental live att-
enuated rubella virus vaccine. Am. J. Dis.
Child. 118: 172—177, 1969.
67. Puschak R., Young M., McKee T.V., Plot-
kin S.A.: Intranasal vaccination with RA
27/3 attenuated rubella virus. J. Pedia-
tric. 79: 55—60, 1971.
68. Rauh J.L.. Schiff G.M., Johnson L.B.: Foll-
ow-up studies of rubella vaccines at adole-
scence. J. Pediatric 86: 138—140, 1975.
69. Schiff G.M., Rauh J.L., Rubella control.
Am. J. Dis. Child. 122: 112—116-. 1971.
70. Schiff G.M., Rauh J.L., Rotte T., Trimble
S.: Two-yecir follow-up of rubella vaccines